CHTF8P1

Across TCGA pan-cancer cohorts, CHTF8P1 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated CHTF8P1 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher CHTF8P1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated CHTF8P1 expression acts as an unfavorable survival marker, although some lineages such as COAD and ESCA show a favorable association.

COAD, LIHC, and ACC are the cancer types where CHTF8P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Quartile	III,IV	0.754	0.445	.001	69	view →
LIHC	DFS	Tertile	All	0.310	0.478	<.001	42	view →
ACC	OS	Tertile	II,III,IV	0.140	0.734	<.001	36	view →
ESCA	DFS	Median	III,IV	0.576	0.328	.007	28	view →
STAD	OS	Quartile	III,IV	0.692	0.277	.026	27	view →
THCA	OS	Tertile	All	0.969	1.000	<.001	26	view →
KIRP	DFS	Tertile	III,IV	0.892	0.161	.007	25	view →
LUSC	OS	Median	II,III,IV	0.612	0.888	.004	22	view →
DLBC	OS	Tertile	III,IV	0.172	1.000	.014	22	view →
SKCM	DFS	Median	III,IV	0.679	0.395	.002	17	view →
GBM	DFS	Quartile	All	0.283	0.170	.015	13	view →
KIRC	DFS	Tertile	All	0.928	0.840	.008	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

CHTF8P1–COAD (OS)

Open the COAD breakdown →